Physician profile
Eric Arvidson
NPI 1689666547
$4,909.87
in general payments reported to CMS, 2019-2025
19 companies · $389 in 2025
The $389 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $112 · 2022: $1,432 · 2023: $470 · 2024: $2,507 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,751 · Travel and Lodging: $1,615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,751.19 |
| Travel and Lodging | $1,614.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,191.20 | 2024-2025 | Journey II, Legion Revision, Journey |
| Stryker Corporation | $1,442.50 | 2022-2025 | Insignia, Mako |
| Zimmer Biomet Holdings, INC. | $540.10 | 2021-2023 | Persona |
| Janssen Biotech, INC. | $132.41 | 2023-2025 | Tremfya |
| Ferring Pharmaceuticals INC. | $107.35 | 2022-2023 | Euflexxa |
| Bioventus LLC | $78.11 | 2022-2024 | Exogen Ultrasound Bone Healing System |
| Novartis Pharmaceuticals Corporation | $63.91 | 2023-2025 | |
| Endo USA, INC. | $58.07 | 2025 | Xiaflex |
| Endo Pharmaceuticals INC. | $48.84 | 2022-2023 | Xiaflex |
| Depuy Synthes Sales INC. | $41.53 | 2023 | Monovisc, Orthovisc |
| Fidia Pharma USA INC. | $40.17 | 2024-2025 | Hymovis, Triluron, Hyalgan |
| Pacira Pharmaceuticals Incorporated | $30.70 | 2024 | Zilretta, Iovera |
| Organon LLC | $27.04 | 2025 | Hadlima |
| Amgen INC. | $23.78 | 2025 | Enbrel, Otezla |
| Sandoz INC. | $20.20 | 2025 | Hyrimoz |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kairos Surgical INC | $17.09 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $16.42 | 2025 | |
| Nalu Medical, INC. | $15.49 | 2024 | Nalu Neurostimulation System |
| Convatec INC. | $14.96 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Arvidson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.